Mirum Pharmaceuticals, Inc.MIRMNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 19 | 77↑302.7% | 186↑141.8% | 337↑80.8% |
| Gross Profit | -1 | 17↑2866.5% | 65↑275.3% | 139↑115.4% | 255↑83.2% |
| Operating Income | -104 | -173↓66.3% | -131↑24.3% | -109↑16.8% | -88↑19.7% |
| Net Income | -103 | -84↑18.7% | -136↓61.5% | -163↓20.5% | -88↑46.2% |
| EBITDA | -102 | -65↑36.1% | -123↓87.9% | -136↓11.1% | -49↑64.1% |
| EPS Diluted | -4.09 | -2.77↑32.3% | -4.02↓45.1% | -4.00↑0.5% | -1.85↑53.8% |